TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

BEIJING TIDE PHARM

OncologyGastroenterology
Generics

BEIJING TIDE PHARM is a generic drug manufacturer focused on Oncology, Gastroenterology.

2021
Since
1
Drugs
-
Trials
7
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

COLESEVELAM HYDROCHLORIDE 2025-04-22
Labeling
COLESEVELAM HYDROCHLORIDE 2025-04-22
Labeling
COLESEVELAM HYDROCHLORIDE 2025-04-18
COLESEVELAM HYDROCHLORIDE 2024-10-11
Labeling
COLESEVELAM HYDROCHLORIDE 2024-10-11
Labeling
COLESEVELAM HYDROCHLORIDE 2024-10-11
Labeling
COLESEVELAM HYDROCHLORIDE 2024-10-11
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 67%
0 drugs Phase 1: 2
Gastroenterology 33%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Gastroenterology
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology
Takeda big-pharma
Oncology, Gastroenterology
Gilead Sciences biotech
Oncology, Gastroenterology
ASTELLAS specialty
Oncology, Gastroenterology